SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001779453-22-000005
Filing Date
2022-12-22
Accepted
2022-12-22 15:17:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D/A epiq_LDHX-13da.htm SC 13D/A 176120
2 EX 99.1 99.1.htm EX-99 4691
  Complete submission text file 0001779453-22-000005.txt   182367
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Subject) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92196 | Film No.: 221481708
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address ONE LOMBARD STREET, SUITE 200 SAN FRANCISCO CA 94111
Business Address ONE LOMBARD STREET, SUITE 200 SAN FRANCISCO CA 94111 415-433-3751
EPIQ Capital Group, LLC (Filed by) CIK: 0001779453 (see all company filings)

IRS No.: 823491906 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A